Community Oncology Connections™: Monotherapies vs Combinations – Navigating Oral SERDs and Targeted Combination Strategies in HR+/HER2- Metastatic Breast Cancer

Tuesday, August 4, 2026
5:15 PM - 6:15 PM CT

This program brings together expert faculty to discuss the latest advances and enable the integration of oral SERDs and emerging combination strategies into HR+/HER2- metastatic breast cancer care.

View Details & Register

Community Oncology Connections™: Advancing Precision Care in HER2-Positive Gastroesophageal Adenocarcinomas: A Collective Curriculum on the Integration of Novel Bispecific Antibody Therapy

Tuesday, September 29, 2026
5:15 PM - 6:15 PM CT

In this series of live, virtual webcasts, experts in the management of esophagogastric adenocarcinoma discuss the evaluation and treatment of HER2-positive disease across the treatment continuum.

View Details & Register

Location

Virtual
Target Audience

This educational program is primarily directed toward a global audience of community-based medical oncologists, surgical oncologists, advanced practice providers, nurses, and other healthcare providers involved in the treatment of metastatic breast cancer and metastatic gastroesophageal cancers (GEAs).

Iowa Oncology Society

Community Oncology Connections™: Monotherapies vs Combinations – Navigating Oral SERDs and Targeted Combination Strategies in HR+/HER2- Metastatic Breast Cancer

Community Oncology Connections™: Advancing Precision Care in HER2-Positive Gastroesophageal Adenocarcinomas: A Collective Curriculum on the Integration of Novel Bispecific Antibody Therapy

Event Details

Related Content

Rhode Island Oncology Society

Medical Crossfire®: Optimizing 𝘌𝘚𝘙1 Mutation Detection and Next-Generation Endocrine Therapy Integration in HR+/HER2– Breast Cancer

Antibody–Drug Conjugates in Oncology: The Essentials of AE Management for Better Patient Outcomes

3rd Annual Hawaii Cancer Conference